Carbon monoxide: from the origin of life to molecular medicine.

Abstract:

:Carbon monoxide, long considered only as a toxic gas, has recently been shown to mediate potent anti-inflammatory and other salutary effects in rodents when it is used at low doses. Carbon monoxide is one of the products of the degradation of heme by heme oxygenase 1. Until recently, these beneficial effects of carbon monoxide were shown only when it was given before a stress stimulus. Hagazi and colleagues have recently shown that this substance is effective even when it is given after a disease process has started. The effects of low doses of carbon monoxide are complemented by the production of biliverdin and probably also by ferritin, which are additional products of heme degradation.

journal_name

Trends Mol Med

authors

Bach FH

doi

10.1016/j.molmed.2006.06.007

subject

Has Abstract

pub_date

2006-08-01 00:00:00

pages

348-50

issue

8

eissn

1471-4914

issn

1471-499X

pii

S1471-4914(06)00137-7

journal_volume

12

pub_type

杂志文章
  • Immune Regulation of Antibody Access to Neuronal Tissues.

    abstract::This review highlights recent advances in how the innate and adaptive immune systems control the blood-brain barrier (BBB) and the blood-nerve barrier (BNB). Interferons and TAM receptors play key roles in innate immune control of the BBB. Cells of the adaptive immune system, particularly CD4+ T cells, take distinct r...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.01.004

    authors: Iwasaki A

    更新日期:2017-03-01 00:00:00

  • Cheating Death: New Molecules Block BAX.

    abstract::BAX is a formidable BCL-2 family protein that executes cellular suicide in response to physiologic and pathologic stress. A new article in Nature Chemical Biology (Garner et al.https://doi.org/10.1038/s41589-018-0223-0) reports small molecules that inhibit the conformational activation of BAX, informing a pharmacologi...

    journal_title:Trends in molecular medicine

    pub_type: 信件

    doi:10.1016/j.molmed.2019.02.008

    authors: Walensky LD

    更新日期:2019-04-01 00:00:00

  • Tracking the elusive prion.

    abstract::Prion diseases are infectious neurodegenerative fatal disorders. There are currently no treatments or cures. Considerable evidence suggests that the infectious agent is an abnormally folded protein that promotes or seeds its normal cellular isoform to fold into the infectious form. However, the precise mechanism and f...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.08.006

    authors: Liebman SW,Mastrianni JA

    更新日期:2005-10-01 00:00:00

  • Promoting brain remodeling to aid in stroke recovery.

    abstract::Endogenous brain repair after stroke involves a set of highly interactive processes, such as angiogenesis, neurogenesis, oligodendrogenesis, synaptogenesis, and axonal outgrowth, which together orchestrate neurological recovery. During the past several years, there have been advances in our understanding of miRNAs and...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2015.07.005

    authors: Zhang ZG,Chopp M

    更新日期:2015-09-01 00:00:00

  • Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

    abstract::While preclinical studies have reported improvement of behavioral deficits in the Ts65Dn mouse model of Down syndrome (DS), translation to human clinical trials to improve cognition in individuals with DS has had a poor success record. Timing of the intervention, choice of animal models, strategy for drug selection, a...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2019.10.001

    authors: Lee SE,Duran-Martinez M,Khantsis S,Bianchi DW,Guedj F

    更新日期:2020-02-01 00:00:00

  • Why have clinical trials in sepsis failed?

    abstract::The systemic inflammatory response is biologically complex, redundant, and activated by both infectious and noninfectious triggers. Its manipulation can cause both benefit and harm. More than 100 randomized clinical trials have tested the hypothesis that modulating the septic response to infection can improve survival...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2014.01.007

    authors: Marshall JC

    更新日期:2014-04-01 00:00:00

  • Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer?

    abstract::Carcinoma of the gastrointestinal tract is the most common internal malignancy affecting men and women in Western countries. Chronic intestinal inflammation, especially of the colon, is also a Western disease and correlates with a significantly increased risk of developing cancer. This has suggested that the immune pr...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(01)02107-4

    authors: Weaver SA,Ward SG

    更新日期:2001-10-01 00:00:00

  • Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm.

    abstract::Medulloblastomas often activate Hedgehog signaling inappropriately. The finding that mutations in components of this pathway are present only in few tumors suggests that additional genetic or epigenetic lesions can also lead to Hedgehog dysregulation. Chromosome 17p deletion, the most frequently detected genetic lesio...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.10.005

    authors: Ferretti E,De Smaele E,Di Marcotullio L,Screpanti I,Gulino A

    更新日期:2005-12-01 00:00:00

  • CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

    abstract::Recent reports on the impressive efficacy of adoptively transferred T cells to challenge cancer in early phase clinical trials have significantly raised the profile of T cell therapy. Concomitantly, general expectations are also raised by these reports, with the natural aspiration to deliver this therapy over a wide r...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2012.04.009

    authors: Gilham DE,Debets R,Pule M,Hawkins RE,Abken H

    更新日期:2012-07-01 00:00:00

  • Foci on fanconi.

    abstract::The protein network protecting the stability of the genome is defective in Fanconi anemia (FA). The newest in a series of FA proteins is involved in DNA damage response, but the mechanism is still unclear. Clues may come from yeast two-hybrid experiments, an extraordinarily successful tool for determining molecular fu...

    journal_title:Trends in molecular medicine

    pub_type: 新闻

    doi:10.1016/s1471-4914(01)02042-1

    authors: Hoatlin M,Reuter T

    更新日期:2001-06-01 00:00:00

  • miRNAs in B Cell Development and Lymphomagenesis.

    abstract::B lymphocytes are essential for an efficient immune response against a variety of pathogens. A large fraction of hematologic malignancies is of B cell origin, suggesting that the development and activation of B cells need to be tightly regulated. In recent years, increasing evidence has emerged demonstrating that micr...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.06.001

    authors: Coffre M,Koralov SB

    更新日期:2017-08-01 00:00:00

  • Chemical Strike against a Dominant-Inherited MUC1-Frameshifted Protein Associated with Progressive Kidney Disease.

    abstract::In a recent paper by Dvela-Levitt et al., chemical screening using an immunofluorescent assay identified a compound that caused removal of a dominant-inherited misfolded secretory protein, mucin1-frameshifted, from an intracellular location in immortalized renal epithelial cells of a patient affected with progressive ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2019.08.011

    authors: Thomas G,Horwich A

    更新日期:2019-10-01 00:00:00

  • Mixing the right hepatitis C inhibitor cocktail.

    abstract::Therapy for hepatitis C virus (HCV) infection is on the cusp of a new era. Until now, standard-of-care therapy has involved interferon (IFN) and ribavirin. With the first successful Phase III trials of specific targeted antiviral therapy for HCV (STAT-C) compounds, as well as three trials in progress giving the first ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2010.10.005

    authors: Gelman MA,Glenn JS

    更新日期:2011-01-01 00:00:00

  • The immunomodulatory capacity of mesenchymal stem cells.

    abstract::Mesenchymal stem cells (MSCs) are currently being tested in clinical trials for the treatment of various diseases owing to the ease of generating and expanding these cells, the ability to differentiate them into various specialized mesenchymal tissue types and their immunosuppressive properties. However, their immunom...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2011.10.004

    authors: Gebler A,Zabel O,Seliger B

    更新日期:2012-02-01 00:00:00

  • Dispelling myths and focusing on notable concepts in HIV pathogenesis.

    abstract::Since the discovery of HIV over three decades ago, major efforts have been made to control and perhaps eliminate HIV infection worldwide. During these studies, certain myths or misconceptions about this infectious disease have been emphasized and other potentially beneficial concepts have received less attention. A tr...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2015.03.004

    authors: Levy JA

    更新日期:2015-06-01 00:00:00

  • Vascular calcification and bone disease: the calcification paradox.

    abstract::Vascular calcification or ectopic mineralization in blood vessels is an active, cell-regulated process, increasingly recognized as a general cardiovascular risk factor. Remarkably, ectopic artery mineralization is frequently accompanied by decreased bone mineral density or disturbed bone turnover. This contradictory a...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2009.07.001

    authors: Persy V,D'Haese P

    更新日期:2009-09-01 00:00:00

  • miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?

    abstract::miRNAs are small noncoding RNAs known to post-transcriptionally regulate gene expression. miRNAs are expressed in the heart where they regulate multiple pathophysiological processes. The discovery of stable cardiac miRNAs in the bloodstream has also motivated the investigation of their potential as biomarkers. This re...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2014.10.006

    authors: Goretti E,Wagner DR,Devaux Y

    更新日期:2014-12-01 00:00:00

  • DHEA: a novel adjunct for the treatment of male trauma patients.

    abstract::Despite significant advances in the management of trauma victims, traumatic injury with the ensuing sepsis and multiple organ failure remains the leading cause of death between the ages of 18 and 44 in the USA. Recently, interest in the clinically and experimentally observed gender dimorphic response to traumatic inju...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(01)01917-7

    authors: Jarrar D,Kuebler JF,Wang P,Bland KI,Chaudry IH

    更新日期:2001-02-01 00:00:00

  • iPSCs: On the Road to Reprogramming Aging.

    abstract::Aging is characterized by irreversible loss of physiological integrity, often accompanied by an organism's loss of function and increased vulnerability to death. Defects in the mechanisms preserving cellular homeostasis over time may give rise to accelerated aging. Somatic cell reprogramming of aged cells can be assoc...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2016.05.010

    authors: Soria-Valles C,López-Otín C

    更新日期:2016-08-01 00:00:00

  • Sense from nonsense: therapies for premature stop codon diseases.

    abstract::Ten percent of inherited diseases are caused by premature termination codon (PTC) mutations that lead to degradation of the mRNA template and to the production of a non-functional, truncated polypeptide. In addition, many acquired mutations in cancer introduce similar PTCs. In 1999, proof-of-concept for treating these...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2012.09.008

    authors: Bidou L,Allamand V,Rousset JP,Namy O

    更新日期:2012-11-01 00:00:00

  • Genome Engineering for Personalized Arthritis Therapeutics.

    abstract::Arthritis represents a family of complex joint pathologies responsible for the majority of musculoskeletal conditions. Nearly all diseases within this family, including osteoarthritis, rheumatoid arthritis, and juvenile idiopathic arthritis, are chronic conditions with few or no disease-modifying therapeutics availabl...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.08.002

    authors: Adkar SS,Brunger JM,Willard VP,Wu CL,Gersbach CA,Guilak F

    更新日期:2017-10-01 00:00:00

  • MLL: a histone methyltransferase disrupted in leukemia.

    abstract::Rearrangements of the MLL gene, which is located at chromosome 11q23, are associated with aggressive acute leukemias in both children and adults. MLL regulates Hox gene expression through direct promoter binding and histone modification. MLL rearrangements occurring in leukemia include MLL fusion genes, partial tandem...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.08.005

    authors: Hess JL

    更新日期:2004-10-01 00:00:00

  • Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

    abstract::Our understanding and utilization of fecal microbiota transplantation (FMT) has jump-started over the past two decades. Recent technological advancements in sequencing and metabolomics have allowed for better characterization of our intestinal microbial counterparts, triggering a surge of excitement in the fields of m...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.01.009

    authors: Frisbee AL,Petri WA Jr

    更新日期:2020-05-01 00:00:00

  • Focus on Fundamentals: Achieving Effective Nanoparticle Targeting.

    abstract::Successful molecular targeting of nanoparticle drug carriers can enhance therapeutic specificity and reduce systemic toxicity. Typically, ligands specific for cognate receptors expressed on the intended target cell type are conjugated to the nanoparticle surface. This approach, often called active targeting, seems to ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2018.05.003

    authors: Tietjen GT,Bracaglia LG,Saltzman WM,Pober JS

    更新日期:2018-07-01 00:00:00

  • Epithelial Plasticity versus EMT in Kidney Fibrosis.

    abstract::Ten percent of the population worldwide suffers from chronic kidney disease (CKD), characterized by fibrotic changes in the kidney. Fibrosis is associated with loss of epithelial parenchyma, and accumulation of myofibroblasts, fibrillary collagen, and inflammatory cells. Two recent papers highlight the critical role o...

    journal_title:Trends in molecular medicine

    pub_type: 评论,杂志文章

    doi:10.1016/j.molmed.2015.11.009

    authors: Huang S,Susztak K

    更新日期:2016-01-01 00:00:00

  • HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease.

    abstract::Cardiovascular diseases predominantly result from atherosclerosis, a natural biological phenomenon reflecting food intake and energy production in humans. Lipolysis of plasma triglyceride-rich lipoproteins (TGRLs) by lipoprotein lipase (LPL) is an essential element of energy production that delivers free fatty acids t...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.07.005

    authors: Kontush A

    更新日期:2020-12-01 00:00:00

  • Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

    abstract::Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system. The inflammatory and neurodegenerative pathways driving MS are modulated by DNA, lysine, and arginine methylation, as evidenced by studies made possible by novel tools for methylation detection or loss of function. We present evid...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.04.004

    authors: Webb LM,Guerau-de-Arellano M

    更新日期:2017-06-01 00:00:00

  • Strengthening Causal Inference for Complex Disease Using Molecular Quantitative Trait Loci.

    abstract::Large genome-wide association studies (GWAS) have identified loci that are associated with complex traits and diseases, but index variants are often not causal and reside in non-coding regions of the genome. To gain a better understanding of the relevant biological mechanisms, intermediate traits such as gene expressi...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.10.004

    authors: Neumeyer S,Hemani G,Zeggini E

    更新日期:2020-02-01 00:00:00

  • Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

    abstract::Non-alcoholic steatohepatitis (NASH), a cause of cirrhosis and hepatocellular carcinoma, is characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and fibrosis. Progress has been made in understanding the molecular and cellular mechanisms implicated in the pathogenesis of this condition,...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2007.12.003

    authors: Marra F,Gastaldelli A,Svegliati Baroni G,Tell G,Tiribelli C

    更新日期:2008-02-01 00:00:00

  • Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.

    abstract::Activated factor Xa (FXa) is traditionally known as an important player in the coagulation cascade responsible for thrombin generation. Long considered a passive bystander, it is now evident that FXa exerts direct effects on a wide variety of cell types via activation of its two main receptors, protease-activated rece...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2008.08.001

    authors: Borensztajn K,Peppelenbosch MP,Spek CA

    更新日期:2008-10-01 00:00:00